New Product Launches Along with Rising Awareness for Treatment of Actinic Keratosis are Propelling the Growth of Global Actinic Keratosis Treatment Market

The global actinic keratosis treatment market is anticipated to grow at a significant CAGR of 5.0% during the forecast period 2022-2028. The major factor driving the growth of the market is the rising awareness regarding actinic keratosis skin disease. The hazardous outcomes of improper treatment of actinic keratosis, turning into skin cancer, are making people go for timely diagnosis and treatment. Moreover, the rise in government initiatives along with new product launches by major players in the market is propelling the growth of the market. 

Browse the full report of " Global Actinic Keratosis Treatment Market Size, Share, and Trends Analysis Report By Type (Medication (Fluorouracil, Imiquimod, Ingesol Mebutate, and Others) and Therapy (Photodynamic Therapy, Laser Surgery, and Others) and By End-User (Hospitals & Oncology Centres, and Dermatology Clinics) Forecast 2022-2028" at https://www.omrglobal.com/industry-reports/actinic-keratosis-treatment-market-share

For instance, in December 2021, Biofrontera Inc., had enrolled in a Phase 1 study to evaluate the safety along with appropriateness of photodynamic therapy (PDT) in order to provide treatment for actinic keratosis (AK) using three tubes of Ameluz coupled with the company’s BF-RhodoLED XL lamp. Further, in July 2021, Athenex, Inc., announced that the Company had entered into licensing agreements and strategic partnerships with Seqirus Pty Ltd., a subsidiary of CSL Ltd., and AVIR Pharma Inc. for tirbanibulin. Apart from this, in December 2020, Athenex, Inc., announced that the US Food and Drug Administration (FDA) had approved Klisyri for the topical treatment of actinic keratosis (AK) on the face or scalp. Additionally, for launching the Klisyri, the company partnered with Almirall in the US.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

Segment Covered- 

• By Type
• By End-User

Regions Covered-

• North America
• Europe
• Asia-Pacific
• Rest of the World

Competitive Landscape - including, 3M Co., Alma Lasers Inc., Almirall SA, Bausch Health Companies Inc., and Biofrontera AG, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity??

Global Actinic Keratosis Treatment Market Report Segment

By Type

• Medication

o Fluorouracil

o Imiquimod

o Ingestol Mebutate

o Others

• Therapy

o Photodynamic Therapy

o Laser Surgery

o Others

By End-User

• Hospitals & Oncology Centers
• Dermatology Clinics

Global Actinic Keratosis Treatment Market Report Segment by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe 

Asia-Pacific

• China
• India
• Japan
• Rest of Asia-Pacific 

Rest of the World

• Latin America 
• Middle East & Africa